Assignee
FORMYCON AG
DE·6 granted patents·16 pending applications·71 citations·filing 2014–2025
Top patents by PatentIndex Score
22 records- 0194US11666632B2Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonistFORMYCON AG·Filed 2022·Granted Jun 6, 2023·3 cites·20 claims
- 0293US10925927B2Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonistFORMYCON AG·Filed 2016·Granted Feb 23, 2021·8 cites·45 claims
- 0393US10576128B2Liquid formulation of a VEGF antagonistFORMYCON AG·Filed 2017·Granted Mar 3, 2020·51 cites·14 claims
- 0491US11298405B2Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonistFORMYCON AG·Filed 2021·Granted Apr 12, 2022·2 cites·19 claims
- 0585US10568951B2Pharmaceutical composition of an anti-VEGF antibodyFORMYCON AG·Filed 2014·Granted Feb 25, 2020·7 cites·11 claims
- 0677US12551529B2Liquid formulation of a VEGF antagonistFORMYCON AG·Filed 2023·Granted Feb 17, 2026·0 cites·10 claims
- 0773US2024366857A1Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonistFORMYCON AG·Filed 2024·Application pending·0 cites
- 0870US2025229010A1Pre-filled plastic syringe containing a vegf antagonistFORMYCON AG·Filed 2025·Application pending·0 cites
- 0968US2022362441A1Pre-filled plastic syringe containing a vegf antagonistFORMYCON AG·Filed 2022·Application pending·0 cites
- 1062US2025082737A1Ace2 fusion proteins and uses thereofFORMYCON AG·Filed 2022·Application pending·0 cites
- 1158US2020237862A1Liquid Formalation of a VEGF AntagonistFORMYCON AG·Filed 2020·Application pending·0 cites
- 1257US2021008284A1Pre-filled plastic syringe containing a VEGF antagonistFORMYCON AG·Filed 2020·Application pending·0 cites
- 1356US2024287185A1Formulations of anti-pd1 antibodiesFORMYCON AG·Filed 2022·Application pending·0 cites
- 1455US2024139296A1Formulations of ace2 fc fusion proteinsFORMYCON AG·Filed 2022·Application pending·0 cites
- 1553US2025027067A1Improved ace2 fusion proteinsFORMYCON AG·Filed 2022·Application pending·0 cites
- 1652US2020237997A1Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonistFORMYCON AG·Filed 2018·Application pending·0 cites
- 1749US2023355757A1Formulations of anti-pd1 antibodiesFORMYCON AG·Filed 2020·Application pending·0 cites
- 1849US2024018499A1ACE2 Fusion Proteins and Uses ThereofFORMYCON AG·Filed 2021·Application pending·0 cites
- 1948US2018326126A1Pre-filled plastic syringe containing a vegf antagonistFORMYCON AG·Filed 2016·Application pending·0 cites
- 2047US2022204920A1Method for reducing methionine oxidation in recombinant proteinsFORMYCON AG·Filed 2020·Application pending·0 cites
- 2145US2021363512A1ACE2 fusion proteins and uses thereofFORMYCON AG·Filed 2021·Application pending·0 cites
- 2238US2017232199A1Pre-Filled Plastic Syringe Containing a VEGF AntagonistFORMYCON AG·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →